Suppr超能文献

肝素对狒狒动脉损伤内膜增生抑制作用的失效。肝素敏感和不敏感途径在平滑肌细胞迁移和增殖刺激中的作用。

Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.

作者信息

Geary R L, Koyama N, Wang T W, Vergel S, Clowes A W

机构信息

Department of Surgery, University of Washington School of Medicine, Seattle 98195-6410, USA.

出版信息

Circulation. 1995 Jun 15;91(12):2972-81. doi: 10.1161/01.cir.91.12.2972.

Abstract

BACKGROUND

Heparin is a potent inhibitor of smooth muscle cell (SMC) growth and intimal hyperplasia in animal models but has been ineffective in inhibiting restenosis in humans. This difference may relate to flaws in clinical study design or, alternatively, to interspecies differences in SMC response to heparin. To determine whether heparin could inhibit intimal hyperplasia in a species more closely related to humans, we studied the effect of a low-molecular-weight heparin (LMWH) on baboon SMC proliferation and migration in culture and in arteries subjected to experimental angioplasty.

METHODS AND RESULTS

LMWH or saline was infused continuously after experimental angioplasty of baboon peripheral arteries (six animals per group). After 28 days, bromodeoxyuridine (BrdU) was given to label proliferating cells, and balloon-injured arteries were perfusion-fixed in situ and removed for analysis. All arteries had reendothelialized (Evans blue dye exclusion). LMWH increased partial thromboplastin time (LMWH, 81.7 +/- 8.4 seconds versus saline, 34.7 +/- 0.8 seconds [mean +/- SEM]; P = .004) but failed to inhibit intimal thickening or SMC proliferation (intimal area: LMWH, 0.19 +/- 0.03 mm2 versus saline, 0.21 +/- 0.03 mm2; BrdU labeling: LMWH, 2.9 +/- 0.6% versus saline, 2.4 +/- 0.4%; P = NS). In culture, LMWH and standard heparin (100 micrograms/mL) significantly inhibited serum-induced but not platelet-derived growth factor (PDGF-BB)-induced SMC proliferation (% control, serum: LMWH, 60.5 +/- 4.0%, P = .0002; standard heparin, 29.4 +/- 8.2%, P = .0001; % control, PDGF-BB: LMWH, 117.7 +/- 11.3%, P = NS; standard heparin, 90.9 +/- 14.4%, P = NS) and SMC migration (% control, serum: LMWH, 15.3 +/- 1.9%, P = .0198; standard heparin, 26.4 +/- 13.8%, P = .0032; % control, PDGF-BB: LMWH, 98.5 +/- 14.3%, P = NS; standard heparin, 100.0 +/- 13.5%, P = NS).

CONCLUSIONS

LMWH failed to inhibit intimal hyperplasia in a baboon angioplasty model. Furthermore, LMWH blocked serum-induced but not PDGF-BB-induced SMC proliferation and migration in culture. Thus, heparin-sensitive and -insensitive pathways exist for SMC activation. The relative importance of each pathway induced by injury may vary between species and thus account for different responses to heparin.

摘要

背景

在动物模型中,肝素是平滑肌细胞(SMC)生长和内膜增生的有效抑制剂,但在抑制人类再狭窄方面却无效。这种差异可能与临床研究设计的缺陷有关,或者与SMC对肝素反应的种间差异有关。为了确定肝素是否能在与人类关系更密切的物种中抑制内膜增生,我们研究了低分子量肝素(LMWH)对狒狒SMC在培养物中以及在接受实验性血管成形术的动脉中的增殖和迁移的影响。

方法与结果

对狒狒外周动脉进行实验性血管成形术后(每组6只动物),持续输注LMWH或生理盐水。28天后,给予溴脱氧尿苷(BrdU)标记增殖细胞,对球囊损伤的动脉进行原位灌注固定并取出进行分析。所有动脉均已重新内皮化(伊文思蓝染料排除法)。LMWH使部分凝血活酶时间延长(LMWH组为81.7±8.4秒,生理盐水组为34.7±0.8秒[平均值±标准误];P = 0.004),但未能抑制内膜增厚或SMC增殖(内膜面积:LMWH组为0.19±0.03mm²,生理盐水组为0.21±0.03mm²;BrdU标记:LMWH组为2.9±0.6%,生理盐水组为2.4±0.4%;P = 无显著性差异)。在培养物中,LMWH和标准肝素(100μg/mL)显著抑制血清诱导的SMC增殖,但不抑制血小板衍生生长因子(PDGF - BB)诱导的SMC增殖(对照组百分比,血清:LMWH组为60.5±4.0%,P = 0.0002;标准肝素组为29.4±8.2%,P = 0.0001;对照组百分比,PDGF - BB:LMWH组为117.7±11.3%,P = 无显著性差异;标准肝素组为90.9±14.4%,P = 无显著性差异)以及SMC迁移(对照组百分比,血清:LMWH组为15.3±1.9%,P = 0.0198;标准肝素组为26.4±13.8%,P = 0.0032;对照组百分比,PDGF - BB:LMWH组为98.5±14.3%,P = 无显著性差异;标准肝素组为100.0±13.5%,P = 无显著性差异)。

结论

在狒狒血管成形术模型中,LMWH未能抑制内膜增生。此外,LMWH在培养物中阻断血清诱导的SMC增殖和迁移,但不阻断PDGF - BB诱导的SMC增殖和迁移。因此,表示SMC激活存在肝素敏感和不敏感途径。损伤诱导的各途径的相对重要性可能因物种而异,从而解释了对肝素的不同反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验